Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 240 citing articles:

Severity and outcomes of Omicron variant of SARS-CoV-2 compared to Delta variant and severity of Omicron sublineages: a systematic review and metanalysis
Pryanka Relan, Nkengafac Villyen Motaze, Kavita Kothari, et al.
BMJ Global Health (2023) Vol. 8, Iss. 7, pp. e012328-e012328
Open Access | Times Cited: 49
COVID-19 breakthrough infections, hospitalizations and mortality in fully vaccinated patients with hematologic malignancies: A clarion call for maintaining mitigation and ramping-up research
Lindsey Wang, David C. Kaelber, Rong Xu, et al.
Blood Reviews (2022) Vol. 54, pp. 100931-100931
Open Access | Times Cited: 64
Clinical Severity of SARS-CoV-2 Omicron Variant Compared with Delta among Hospitalized COVID-19 Patients in Belgium during Autumn and Winter Season 2021–2022
Nina Van Goethem, Pui Yan Jenny Chung, Marjan Meurisse, et al.
Viruses (2022) Vol. 14, Iss. 6, pp. 1297-1297
Open Access | Times Cited: 63
SARS-CoV-2 infection in pediatric population before and during the Delta (B.1.617.2) and Omicron (B.1.1.529) variants era
Haifa Khemiri, Kaouther Ayouni, Henda Triki, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 63
Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern in real-world: a literature review and meta-analysis
Weihao Shao, Xiaorui Chen, Caifang Zheng, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2383-2392
Open Access | Times Cited: 62
COVID infection rates, clinical outcomes, and racial/ethnic and gender disparities before and after Omicron emerged in the US
Lindsey Wang, Nathan A. Berger, David C. Kaelber, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 58
Pregnancy outcomes after SARS-CoV-2 infection in periods dominated by delta and omicron variants in Scotland: a population-based cohort study
Sarah J. Stock, Emily Moore, Clara Calvert, et al.
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 12, pp. 1129-1136
Open Access | Times Cited: 58
Risk of severe clinical outcomes among persons with SARS-CoV-2 infection with differing levels of vaccination during widespread Omicron (B.1.1.529) and Delta (B.1.617.2) variant circulation in Northern California: A retrospective cohort study
Jacek Skarbinski, Mariah S. Wood, Tyler C. Chervo, et al.
The Lancet Regional Health - Americas (2022) Vol. 12, pp. 100297-100297
Open Access | Times Cited: 57
Omicron Genetic and Clinical Peculiarities That May Overturn SARS-CoV-2 Pandemic: A Literature Review
Giorgio Tiecco, Samuele Storti, Melania Degli Antoni, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 1987-1987
Open Access | Times Cited: 55
Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study
Nicole Ngai Yung Tsang, Hau Chi So, Benjamin J. Cowling, et al.
The Lancet Infectious Diseases (2022) Vol. 23, Iss. 4, pp. 421-434
Open Access | Times Cited: 52
Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2?
Vivek P. Chavda, Vasso Apostolopoulos
Vaccines (2022) Vol. 10, Iss. 3, pp. 367-367
Open Access | Times Cited: 47
COVID-19 disease severity in US Veterans infected during Omicron and Delta variant predominant periods
Florian Mayr, Victor B. Talisa, Alexander D. Castro, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 44
Covid-19: virology, variants, and vaccines
Megan Young, Harry Crook, J. T. Scott, et al.
BMJ Medicine (2022) Vol. 1, Iss. 1, pp. e000040-e000040
Open Access | Times Cited: 43
The Vaccine Efficacy Against the SARS-CoV-2 Omicron: A Systemic Review and Meta-Analysis
Yuntao Zou, Doudou Huang, Qian Jiang, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 41
Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences
Reem Hoteit, Hadi M. Yassine
Vaccines (2022) Vol. 10, Iss. 6, pp. 919-919
Open Access | Times Cited: 38
Reduction of the risk of severe COVID-19 due to Omicron compared to Delta variant in Italy (November 2021 – February 2022)
Daniele Petrone, Alberto Mateo‐Urdiales, Chiara Sacco, et al.
International Journal of Infectious Diseases (2023) Vol. 129, pp. 135-141
Open Access | Times Cited: 34
Assessing COVID-19 vaccine effectiveness against Omicron subvariants: Report from a meeting of the World Health Organization
Daniel R. Feikin, Melissa M. Higdon, Nick Andrews, et al.
Vaccine (2023) Vol. 41, Iss. 14, pp. 2329-2338
Open Access | Times Cited: 29
The influence of COVID-19 risk perception and vaccination status on the number of social contacts across Europe: insights from the CoMix study
James Wambua, Neilshan Loedy, Christopher I Jarvis, et al.
BMC Public Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 26
Population-Based Evaluation of Vaccine Effectiveness against SARS-CoV-2 Infection, Severe Illness, and Death, Taiwan
Cheng-Yi Lee, Hung-Wei Kuo, Yulun Liu, et al.
Emerging infectious diseases (2024) Vol. 30, Iss. 3
Open Access | Times Cited: 7
Early estimates of SARS-CoV-2 Omicron variant severity based on a matched cohort study, Ontario, Canada
Ana Cecilia Ulloa, Sarah A. Buchan, Nick Daneman, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 50
Dynamics of a national Omicron SARS-CoV-2 epidemic during January 2022 in England
Paul Elliott, Oliver Eales, Barbara Bodinier, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 35
Facing the Omicron variant—how well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review
Wiebe Külper-Schiek, Vanessa Piechotta, Antonia Pilic, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 35
Endothelial Dysfunction in COVID-19: Potential Mechanisms and Possible Therapeutic Options
Maria Chiara Pelle, Isabella Zaffina, Stefania De Luca, et al.
Life (2022) Vol. 12, Iss. 10, pp. 1605-1605
Open Access | Times Cited: 34
Epidemiology of infections with SARS-CoV-2 Omicron BA.2 variant in Hong Kong, January-March 2022
Yonatan Mefsin, Dongxuan Chen, Helen S. Bond, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 33
A comprehensive review on Covid-19 Omicron (B.1.1.529) variant
R. Manjunath, Santosh L. Gaonkar, Ebraheem Abdu Musad Saleh, et al.
Saudi Journal of Biological Sciences (2022) Vol. 29, Iss. 9, pp. 103372-103372
Open Access | Times Cited: 31

Scroll to top